Gene expression profiling of exercise-induced cardiac hypertrophy in rats

被引:41
作者
Iemitsu, M
Maeda, S [1 ]
Miyauchi, T
Matsuda, M
Tanaka, H
机构
[1] Univ Tsukuba, Ctr Tsukuba Adv Res Alliance, Tsukuba, Ibaraki 3058577, Japan
[2] Univ Tsukuba, Inst Hlth & Sport Sci, Tsukuba, Ibaraki 305, Japan
[3] Univ Tsukuba, Inst Clin Med, Tsukuba, Ibaraki 305, Japan
[4] Univ Wisconsin, Dept Kinesiol, Madison, WI USA
来源
ACTA PHYSIOLOGICA SCANDINAVICA | 2005年 / 185卷 / 04期
关键词
calcineurin-inhibitor; endothelin-1; exercise training; glycogen synthase kinase-3 beta; left ventricle;
D O I
10.1111/j.1365-201X.2005.01494.x
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Aims: Exercise training causes physiological cardiac hypertrophy, which acts to enhance cardiac function during exercise. However, the underlying molecular mechanisms are unclear. We investigated gene expression profile of exercise training-induced cardiac hypertrophy using left ventricle (LV) excised from exercise-trained and sedentary control rats (12-week old). Method: Rats in the training group exercised on a treadmill for 8-week. Results: Left ventricular mass index and wall thickness in the exercise-trained group were significantly greater than that in the control group, indicating that the trained rats developed cardiac hypertrophy. Of the 3800 genes analysed in the microarray analyses, a total of 75 relevant genes (upregulation of 33 genes and downregulation of 42 genes) displayed alterations with exercise training. Among these genes, we focused on glycogen synthase kinase (GSK)-3 beta, calcineurin-inhibitor (Cain), and endothelin (ET)-1 for their implicated roles in pathological cardiac hypertrophy, and confirmed the results of microarray analysis at mRNA and protein/peptide levels using quantitative PCR, Western blot, and EIA analyses. The gene expression of GSK-3 beta decreased significantly and those of Cain and ET-1 increased significantly with exercise training. Furthermore, LV mass index was significantly correlated with GSK-3 beta protein activity (r = -0.70, P < 0.01) and tissue ET-1 concentration (r = 0.52, P < 0.05). There were no changes in gene expressions in brain natriuretic peptide (BNP), angiotensin-correcting enzyme (ACE), interleukin-6, and vascular cell adhesion molecule (VCAM)-1. Conclusion: These findings suggest that physiological and pathological LV hypertrophy may share some of the same molecular mechanisms in inducing LV hypertrophy (e.g. GSK-3 beta, Cain, and ET-1) and that other genes (e.g. BNP, ACE) may differentiate physiological from pathological LV hypertrophy.
引用
收藏
页码:259 / 270
页数:12
相关论文
共 36 条
[1]   Activated glycogen synthase-3β suppresses cardiac hypertrophy in vivo [J].
Antos, CL ;
McKinsey, TA ;
Frey, N ;
Kutschke, W ;
McAnally, J ;
Shelton, JM ;
Richardson, JA ;
Hill, JA ;
Olson, EN .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (02) :907-912
[2]   PKCα regulates the hypertrophic growth of cardiomyocytes through extracellular signal-regulated kinase1/2 (ERK1/2) [J].
Braz, JC ;
Bueno, OF ;
De Windt, LJ ;
Molkentin, JD .
JOURNAL OF CELL BIOLOGY, 2002, 156 (05) :905-919
[3]   ALTERATIONS IN GENE-EXPRESSION IN THE RAT-HEART AFTER CHRONIC PATHOLOGICAL AND PHYSIOLOGICAL LOADS [J].
BUTTRICK, PM ;
KAPLAN, M ;
LEINWAND, LA ;
SCHEUER, J .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1994, 26 (01) :61-67
[4]   Small guanine nucleotide-binding proteins and myocardial hypertrophy [J].
Clerk, A ;
Sugden, PH .
CIRCULATION RESEARCH, 2000, 86 (10) :1019-1023
[5]   Targeted inhibition of calcineurin attenuates cardiac hypertrophy in vivo [J].
De Windt, LJ ;
Lim, HW ;
Bueno, OF ;
Liang, QR ;
Delling, U ;
Braz, JC ;
Glascock, BJ ;
Kimball, TF ;
del Monte, F ;
Hajjar, RJ ;
Molkentin, JD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (06) :3322-3327
[6]   Calcineurin is activated in rat hearts with physiological left ventricular hypertrophy induced by voluntary exercise training [J].
Eto, Y ;
Yonekura, K ;
Sonoda, M ;
Arai, N ;
Sata, M ;
Sugiura, S ;
Takenaka, K ;
Gualberto, A ;
Hixon, ML ;
Wagner, MW ;
Aoyagi, T .
CIRCULATION, 2000, 101 (18) :2134-2137
[7]  
Fagard Robert H., 1997, Cardiology Clinics, V15, P397
[8]   Glycogen synthase kinase-3β is a negative regulator of cardiomyocyte hypertrophy [J].
Haq, S ;
Choukroun, G ;
Kang, ZB ;
Ranu, H ;
Matsui, T ;
Rosenzweig, A ;
Molkentin, JD ;
Alessandrini, A ;
Woodgett, J ;
Hajjar, R ;
Michael, A ;
Force, T .
JOURNAL OF CELL BIOLOGY, 2000, 151 (01) :117-129
[9]   Glycogen synthase kinase-3β -: A novel regulator of cardiac hypertrophy and development [J].
Hardt, SE ;
Sadoshima, J .
CIRCULATION RESEARCH, 2002, 90 (10) :1055-1063
[10]   Cardiac hypertrophy by hypertension and exercise training exhibits different gene expression of enzymes in energy metabolism [J].
Iemitsu, M ;
Miyauchi, T ;
Maeda, S ;
Sakai, S ;
Fujii, N ;
Miyazaki, H ;
Kakinuma, Y ;
Matsuda, M ;
Yamaguchi, I .
HYPERTENSION RESEARCH, 2003, 26 (10) :829-837